الفهرس 
HEPATOCELLULAR CARCINOMAOnly 14 pages are availabe for public view
 |  | from | 32 |  |  |
| | | from | 32 | | |
Abstract
The present study aims at the assement of the clinical usefulness of serum annexin a2 level as a biomarker for diagnosis of hepatocellular carcinoma (HCC) and to evaluate its relationship with clinicopathologcal features of HCC patients.